|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Prepublished online as a Blood First Edition Paper on May 24, 2002; DOI 10.1182/blood-2002-01-0260.
CHEMOKINES
From the Division of Immunobiology, Institute for
Genetic Medicine, Hokkaido University, Sapporo, Japan.
Dendritic cells (DCs) possess numerous dendrites that may be of
great advantage to interaction with T cells. However, it has been
poorly understood how the dendritic morphology of a DC is controlled.
In the present study, using a murine spleen-derived DC line, we
analyzed effects of CCR7 ligands, CCL19 and CCL21, on dendritic
morphology. Mature DCs, but not immature DCs, showed vigorous migration
to either CCL19 or CCL21. CCL19 also rapidly (within 30 minutes)
induced marked extension of dendrites of mature DCs that was maintained
at least for 24 hours. On the other hand, CCL21 failed to induce rapid
dendritic extension, even though a modest dendritic extension of mature
DCs, compared to that by CCL19, was induced 8 or 24 hours after
treatment with CCL21. In addition, pretreatment with a high
concentration of CCL21 significantly inhibited the rapid dendritic
extension induced by CCL19. Thus, it is suggested that CCL19 and CCL21
exert agonistic and antagonistic influences on the initiation of
dendritic extension of mature DCs. The CCL19-induced morphologic
changes were completely blocked by Clostridium difficile
toxin B that inhibits Rho guanosine triphosphatase proteins such as
Rho, Rac, and Cdc42, but not by Y-27632, a specific inhibitor for
Rho-associated kinase. These findings suggest that Rac or Cdc42 (or
both), but not Rho, are involved in the CCL19-induced dendritic
extension of mature DCs.
(Blood. 2002;100:1948-1956) Dendritic cells (DCs) are potent antigen-presenting
cells (APCs) and play major roles in the regulation of immune responses to various antigens.1-3 DCs exhibit a unique ability to
activate naive T cells. The antigen-presenting capability of DCs
depends on their maturational stage. Immature DCs are present in almost all tissues and internalize antigens from the environment with high
efficiency, but exhibit no considerable APC activity to naive T cells.
On encountering foreign antigens, these immature DCs are rapidly
activated and mature by complex processes.2,3 The mature
DCs highly express major histocompatibility (MHC) and costimulatory
molecules including CD80, CD86, and CD40 on the surface, which are
associated with the capability of potent antigen presentation.
During the maturational processes, DCs also change surface expressions
of chemokine receptors to migrate from each peripheral tissue to the
regional lymph nodes (LNs). Chemokines are small proteins, with
molecular weight around 10 kDa, that regulate the migration and the
subsequent distribution of leukocytes.4-8 Chemokines are
divided into at least 4 subfamilies (CXC, CC, C, and CX3C) depending on the number of cysteines and the space between the first 2 cysteines. These chemokines bind G protein-coupled receptors with
7-transmembrane domains.9-11 On mature DCs only high
densities of CCR7, which is a chemokine receptor for CCL19
(Epstein-Barr virus-induced receptor ligand chemokine [ELC]) and
CCL21 (secondary lymphoid tissue chemokine [SLC]), are
expressed.12-14 Both CCL19 and CCL21 are constitutively
and highly expressed in LNs and spleen.15,16 Recently, it
has been reported that mature DCs fail to migrate into the regional LNs
and, thereby, adaptive immune responses are abolished in CCR7-knockout
mice.17 Thus, interaction between CCR7 and its ligands,
CCL19 and CCL21, is an essential process for migration of mature DCs
into the regional LNs. However, it has been totally unclear whether
CCL19 and CCL21 play some roles in the regulation of the
morphologic, phenotypical, and functional properties of mature DCs.
Rho guanosine triphosphatase (GTPase) proteins such as Rho,
Rac, and Cdc42 belong to Ras superfamily and act as molecular switches
to control cellular processes by cycling between active (GTP-bound) and
inactive (GDP-bound) states.18 Rho GTPase proteins control the organization of the actin cytoskeleton. Indeed, Rho, Rac,
and Cdc42 have been characterized well as morphologic regulators in
fibroblasts.19-23 Rho is involved in the bundling of actin
filaments into stress fibers and the clustering of integrins and
associated proteins into focal adhesion complexes. Rac promotes actin
polymerization at the cell periphery to form lamellipodial extension
and membrane ruffles. Cdc42 triggers actin polymerization to form
filopodia or microspikes. Thus, it seems that Rho GTPase proteins are
involved in various morphologic changes in cells.
Mature DCs possess numerous dendrites, which may be of great advantage
in interactions with T cells. However, it has been poorly understood
how the dendritic morphology of DCs is controlled. Stable DC lines are
needed to elucidate the molecular mechanisms underlying the regulation
of dendritic morphology during DC activation. Winzler and
colleagues24 established a growth factor-dependent immature DC line from splenocytes of adult C57BL/6 mice. Although this
DC line showed an immature phenotype, various activating signals such
as living bacteria, lipopolysaccharide (LPS), or cytokines including
tumor necrosis factor- Reagents
Preparation of DCs
Spleen-derived DCs (SPDCs) were generated from C57BL/6 (B6) splenocytes. B6 female mice were purchased from Japan SLC (Hamamatsu, Shizuoka, Japan). Spleens were removed from B6 mice (6-9 weeks of age) and single-cell suspensions were prepared by passing through a stainless mesh. Erythrocytes were lysed by treatment with ammonium chloride. Remaining unfractionated cell populations were plated at a density of 1 × 106 cells/mL in R1 medium. Cultures were fed with fresh R1 medium every 3 to 4 days. On day 14 of the culture, suspended and weakly adherent cells (DC-enriched fraction) were collected by treatment with 3 mM EDTA (ethylenediaminetetraacetic acid). DCs were then positively selected using anti-CD11c (N418) MicroBeads and MACS column (Miltenyi Biotec, Auburn, CA). The purified cells were routinely more than 90% CD11c+ and used as SPDCs. SPDCs expressed moderate levels of MHC class II and CD86, and these expressions were markedly enhanced by treatment with LPS (data not shown). SPDCs (2 × 105 cells/mL) treated with 5 µg/mL LPS for 24 hours were used as mature SPDCs. Chemotaxis assay Chemotaxis assay was conducted as described.32,33 In brief, 1.5 × 105 BC1 cells were added to upper wells of 5-µm pore, polycarbonate 24-well tissue culture inserts (Costar, Cambridge, MA) in 100 µL, with 600 µL chemokine or medium in the bottom wells. All migration assays were conducted in IMDM with 2% FCS in 5% CO2 for 90 minutes at 37°C. Migrated cells recovered from each lower well were counted using comparison to a known number of beads as an internal standard (Flow-Count, Coulter, Miami, FL) as described.27,28 The percent migration was determined from numbers of the starting cells and the migrated cells.Confocal microscopy A space of 0.25 mm thickness was made between a slide glass and a cover glass, and BC1 cells (1 × 106 cells/mL) were infused into the space in the presence or absence of CCL19 or CCL21. The cells were incubated for 15 to 120 minutes at 37°C. In the case of pretreatment with CCL21, the cells were pretreated with CCL21 (1 µg/mL) for 15 minutes on ice; then the cells were cultured on the slide glass with CCL19 (20 ng/mL) and CCL21 (1 µg/mL) for 60 minutes at 37°C. The cell morphology was analyzed using a confocal microscopy (BX61-2CHAr-HeNeG-SP, FV500, Ver3.1, Olympus, Tokyo, Japan). The number of spread cells with long dendrites was counted by 2 observers in a blind fashion and the percentage was calculated. Approximately 100 cells observed in the field of 0.407 mm2 were counted based on their morphology at each point. The data are presented as the mean percentage ± SE of 4 independent experiments.Microscopy The BC1 cells (6 × 104 cells) were cultured using 48-well culture plates in the presence or absence of CCL19 or CCL21 for 2 to 24 hours at 37°C. In some experiments, cells were pretreated with PTX (100 ng/mL) for 2 hours at 37°C. Pretreatment of cells with toxin B or Y-27632 was performed for 5 hours at 37°C. The cell morphology was analyzed by invert microscopy (IX70, Olympus). The number of spread cells with long dendrites was counted by 2 observers in a blind fashion and the percentage was calculated. One hundred to 200 cells were counted based on their morphology at each point. The data are presented as the mean percentage ± SE of 4 independent experiments.Mature SPDCs were preincubated in the absence of chemokines for 4 hours at 37°C to decrease the constitutive extension of dendrites. The cells were then harvested and cultured at a density of 6 × 104 cells/300µL/well using 48-well culture plates in the presence or absence of chemokines for 90 minutes at 37°C. The cell morphology was analyzed by invert microscopy (IX70, Olympus). Statistical analyses In chemotaxis assays, statistical differences compared with the control were calculated by the Dunnett test. In other experiments, the Student t test was used to analyze data for significant differences. Differences between groups were considered significant at P < .05.
Migratory responses of immature and mature DCs to CCL19 and CCL21 Using BC1 cells, we first compared the migratory responses of immature and mature DC to CCR7 ligands, CCL19 and CCL21. We have reported that unstimulated BC1 cells are phenotypically and functionally immature DCs.31 BC1 cells treated with LPS for 24 hours were used as mature DCs. It has been reported that LPS promotes DC maturation and the mature DCs express CCR7 to migrate into the regional LNs.12-14 Immature DCs showed negligible migration to CCL19 or CCL21 (Figure 1). In contrast, mature DCs vigorously migrated to either CCL19 or CCL21. The considerable migration of mature DCs to CCL19 was observed at concentrations of 0.16 to 100 ng/mL (0.017-10.6 nM) with a peak at 4 ng/mL (0.426 nM) and a subsequent decrease at 20 and 100 ng/mL (2.13-10.6 nM). CCL19-induced migration was statistically greater than that of control (without chemokine) at 0.8 ng/mL (0.085 nM; P < .05) and 4 ng/mL (0.426 nM; P < .01). On the other hand, the migration of mature DCs to CCL21 increased at concentrations of 0.8 to 100 ng/mL (0.067-8.33 nM) in a dose-dependent manner. The CCL21-induced migration was statistically greater than that of control at 4 ng/mL (0.333 nM; P < .05), 20 ng/mL (1.67 nM; P < .01), and 100 ng/mL (8.33 nM; P < .01).
Dendritic extension induced by CCL19 and CCL21 As described in the prior section, BC1 cells treated with LPS for 24 hours were used as mature DCs. These mature DCs were then treated with CCL19 or CCL21 in a space between a slide glass and a cover glass, and their morphologic changes were analyzed using confocal microscopy. Before treatment with chemokines, mature DCs had a round shape and possessed short dendrites (Figure 2A,B). After treatment with CCL19 at 20 or 100 ng/mL (2.13 or 10.6 nM) for 1 hour, the cells were spread and their dendrites were markedly extended; 4 ng/mL (0.426 nM) CCL19 also induced a similar but modest morphologic change compared with those at higher doses of CCL19 (Figure 2A). By contrast, no obvious change of dendritic morphology was detected after treatment of mature BC1 cells with CCL21 up to 100 ng/mL (8.33 nM) for 1 hour (Figure 2A,B).
We next analyzed the time course of morphologic changes of mature DCs treated with 20 ng/mL (2.13 nM) CCL19 or 100 ng/mL (8.33 nM) CCL21. In these experiments, the cells were cultured in a space between a slide glass and a cover glass for 15 minutes to 2 hours or in 48-well culture plates for 2 to 4 hours, and the morphologic changes were analyzed using confocal microscopy or invert microscopy, respectively. Long-time culture more than 2 hours of BC1 cells on the slide glass resulted in the low cell viability (data not shown). CCL19 rapidly (at 30 minutes) induced dendritic extension and the
extension was maintained at least for 24 hours (Figures 3 and 4).
Aggregations of the mature DCs were observed in cultures with medium
alone from 4 to 24 hours (Figure 4). No such marked aggregations were
detected in cultures with either chemokine except that with CCL21 at 4 hours. It was also shown in Figures 2 and 4 that CCL21 induced no
considerable morphologic change until 2 hours after the treatment.
CCL21 increased the cell aggregations but not dendritic extension at 4 hours. CCL21-induced dendritic extension of BC1 cells could be detected
at 8 or 24 hours, although the dendritic extension was not so
impressive compared with that induced by CCL19 (Figure 4). Similar
results were obtained with a higher concentration of CCL21 (1 µg/mL,
83.3 nM) (data not shown). Morphology of immature DCs (unstimulated BC1
cells) was unaffected by treatment with either CCL19 or CCL21 (data not
shown).
Effect of CCL21 on rapid dendritic extension induced by CCL19 It has been reported that both CCL19 and CCL21 bind to CCR7 and attract the CCR7-expressing cells in the migratory responses.15,16,34,35 Thus, if rapid dendritic extension induced by CCL19 but not by CCL21 could be mediated via CCR7, CCL21 might compete with CCL19 in interaction with CCR7 and exert an inhibitory effect on the rapid morphologic change. To examine this possibility, we analyzed the effect of CCL21 on the dendritic extension at 1 hour after stimulation with CCL19. Mature BC1 cells were pretreated with a high concentration of CCL21 (1 µg/mL, 83.3 nM) for 15 minutes on ice, and then treated with CCL19 (20 ng/mL, 2.13 nM) in a space between a slide glass and a cover glass for 1 hour at 37°C. The morphologic properties of the cells were observed using confocal microscopy, and proportions of spread cells with long dendrites were calculated (Figure 5A,B). In the control culture without chemokines, the mean proportion of spread cells with long dendrites was less than 5%. CCL19 markedly increased the proportion of spread cells with long dendrites up to more than 60% (Figure 5B). Again no obvious change of the dendritic morphology was detected in mature BC1 cells 1 hour after treatment with the high concentration of CCL21 alone (Figure 5A,B). It should be noted in Figure 5, panels A and B, that pretreatment with a high concentration of CCL21 completely inhibited the CCL19-induced increase in the proportion of spread cells with long dendrites.
Effect of PTX on CCL19-induced dendritic extension Pertussis toxin specifically inhibits Gi/Go proteins among other G-proteins such as Gq, Gs, or G12/G13 proteins, which results in inhibition of cell migration induced by chemokines. Indeed, it has been reported that CCL19-induced chemotaxis of mature DCs is inhibited by PTX at 100 ng/mL.14 Then, we examined whether PTX also inhibited CCL19-induced morphologic changes of mature DCs. Mature DCs were pretreated with PTX at 100 ng/mL for 2 hours, and then treated with CCL19 for 2 hours at 37°C. The morphologic properties of the cells were analyzed using invert microscopy, and the proportions of spread cells with long dendrites were calculated. CCL19 again markedly increased the proportion of spread cells with long dendrites up to approximately 70% (Figure 6A,B). It should be noted in Figure 6, panel B, that the CCL19-induced morphologic changes of mature BC1 cells are almost completely inhibited by PTX.
Effect of inhibitors for Rho GTPase-mediated pathways on CCL19-induced dendritic extension Rho GTPase family including Rho, Rac, and Cdc42 is involved in morphologic change of fibroblasts.19-23 We then examined the effect of Y-27632 and C difficile toxin B on CCL19-induced dendritic extension. Y-27632 is a specific inhibitor for Rho-associated kinase that is a target molecule of Rho36 and C difficile toxin B is an inhibitor for Rho GTPase proteins including Rho, Rac, and Cdc42.37 It has been reported that Y-27632 at 10 µM blocks neurite retraction in neuroblastoma,38 whereas toxin B at 1 to 100 ng/mL inhibits endocytosis of murine DCs and phagocytosis of rat basophil leukemia mast cells that need Rac1 and Cdc42 activations.39,40 Mature DCs were pretreated with Y-27632 (10 µM) or toxin B (4 ng/mL) for 5 hours, and then treated with medium alone or CCL19 (20 ng/mL, 2.13 nM) for 2 hours at 37°C. In the control culture without inhibitors and chemokines, the mean proportion of spread cells with long dendrites was 3.7% (Figure 7B). CCL19 markedly increased the proportion of spread cells with long dendrites up to 74.4%. Pretreatment with Y-27632 induced moderate dendritic extension and increased the proportion of spread cells with long dendrites to 14.8% even in the absence of CCL19. In the presence of CCL19, pretreatment with Y-27632 enhanced the morphologic changes and significantly increased the proportion of spread cells with long dendrites to 81.3% (P < .05 versus CCL19 alone-treated culture). In contrast, no spread cells with long dendrites were observed in toxin B-pretreated cultures either in the absence or presence of CCL19 (Figure 7B).
CCL19-induced dendritic extension of SPDCs To examine whether CCL19-induced dendritic extension is observed in other DC systems, SPDCs were generated by culturing B6 splenocytes in the presence of GM-CSF and fibroblast supernatant for 14 days. SPDCs expressed moderate levels of MHC class II (I-Ab) and CD86, and these expressions were markedly enhanced by treatment with LPS (data not shown). Then, SPDCs treated with LPS for 24 hours were used as mature SPDCs, and these mature SPDCs were treated with CCL19 (20 ng/mL) or CCL21 (100 ng/mL) for 90 minutes. Figure 8 shows that dendrites of mature SPDCs are markedly extended by treatment with CCL19 but not by CCL21. These findings are consistent with prior observations with the BC1 cell line.
CCL19 and CCL21 are selective agonists for CCR7 and drive the migration of T cells and mature DCs into the LNs.12-16,34,35 The role of CCL19 and CCL21 in the cellular traffic into and within secondary lymphoid tissues is well documented.15,16,35 Both CCL19 and CCL21 induce integrin-dependent adhesion and chemotaxis.15,16,34,35 Using in situ hybridization in mice, previous studies show that CCL21 is expressed in the high-endothelial venules (HEVs) and stromal cells of the T-cell zone of the LNs, whereas CCL19 is expressed in the stromal cells of the T-cell zone but not in the HEVs.41-43 These findings suggest that CCL21 is involved in T-cell arrest via integrin activation on the HEVs and the subsequent recruitments of the T cells into the T-cell area. On the other hand, CCL19 appears to be involved in the T-cell recruitment within LNs but not the T-cell arrest on the HEVs. Similarly, it seems that mature DCs are recruited into the T-cell area of LNs by either CCL19 or CCL21. From these observations, it has been considered that CCL19 and CCL21 play different roles in recruitment of T cells and mature DCs into the T-cell area. However, apart from the cellular traffic, functional differences between CCL21 and CCL19 have been poorly understood. In the present study, we have investigated functional roles of CCL19 and CCL21 especially in the morphologic change of murine DCs. It was clearly demonstrated that CCL19 but not CCL21 rapidly and markedly induced morphologic changes of mature DCs. It should be noted that the marked dendritic extension of DCs was observed in the presence of more than 20 ng/mL CCL19 (Figures 1 and 3). On the other hand, migration of mature DCs was vigorously promoted by a broad concentration (0.8-100 ng/mL) of CCL19 with a peak at 4 ng/mL (Figure 1). Thus, high concentrations of CCL19 appeared to be needed to induce the dendritic extension compared to those required for chemotactic response. These findings suggest that low concentrations of CCL19 mainly participate in the recruitment of mature DCs to the T-cell areas of the draining LNs. It appears that marked dendritic extensions of DCs are then promoted in the T-cell area where large amounts of CCL19 produced by the stromal cells are present.41 On the other hand, the CCL19-induced migration of mature DCs may be decreased in the presence of high concentrations of CCL19. The morphologic changes induced by the high concentration of CCL19 seem to be related to the diminished migration of DCs. CCL21 and CCL19 bind specifically to CCR7 with a similar affinity and exert similar effects on integrin activation and chemotaxis of T cells and mature DCs.15,16,34,35 In agreement with previous reports,12-14 we found that both CCL19 and CCL21 vigorously promoted migration of mature DCs (Figure 1). In contrast, concerning morphologic changes, CCL19 at 20 ng/mL (2.13 nM) markedly induced rapid dendritic extension of mature DCs, whereas CCL21 up to 1 µg/mL (83.3 nM) induced no rapid dendritic extension (Figures 2, 3, and 5). In addition, the CCL19-induced dendritic extension was almost completely inhibited by pretreatment with a high concentration of CCL21 (Figure 5). It has been reported that certain chemokine receptors have natural antagonistic ligands.44,45 For instance, monocyte chemotactic protein 3 (MCP-3) binds to CCR5, but the MCP-3-CCR5 binding leads to no functional activation and competitively inhibits the binding of other ligands.44 Thus, although the interaction between CCL21 and CCR7 induced enhanced migratory response, the interaction might result in no functional influences on rapid dendritic extension of mature DC. It seemed that CCL19 and CCL21 exhibited phenotypically agonistic and antagonistic properties in the morphologic regulation of mature DCs, respectively. At present time, we consider that CCL19-CCR7 interaction may introduce at least 2 different signals that are involved in the chemotaxis or the rapid dendritic extension, respectively. On the other hand, the intracellular signals induced by CCL21-CCR7 interaction may be involved in the chemotaxis but not in the rapid dendritic extension of mature DCs. However, at the later stages, CCL21 also induced modest dendritic extension of DCs as compared with that induced by CCL19 at the same later stages. Although we consider that the dendritic extension of DCs at the later stages is also mainly regulated by CCL19, the distinct role of CCL19 and CCL21 in the dendritic extension should be carefully analyzed in future investigations. Chemokine receptors are coupled with Gi proteins, and PTX that inhibits specifically Gi/Go proteins but not other G-proteins such as Gq, Gs, or G12/G13 proteins46 abrogates cell migrations induced by chemokines.46-48 Indeed, CCL19-induced chemotaxis of mature DCs is inhibited by treatment with PTX.14 In the present study, it was shown that PTX also inhibited CCL19-induced dendritic extension of mature DCs (Figure 6). Thus, Gi proteins coupled with CCR7 appear to be involved in signal pathways related to not only chemotaxis but also regulation of dendritic morphology in mature DCs. It has been reported that Gi proteins are involved in Ras activation in mammalian cells.49 Ras regulates activation of extracellular signal-related kinase (ERK).49 In the present study, we found that CCL19-induced dendritic extension was unaffected by treatment with PD98059, a specific inhibitor of ERK pathway (data not shown). Thus, it seems unlikely that the ERK pathway is involved in the CCL19-induced morphologic change. Recently, it has been demonstrated that Gi proteins are also involved in activation of Rac and Cdc42 in mouse fibroblasts.50 We showed herein that the CCL19-induced dendritic extension of mature DCs was completely inhibited by toxin B, a specific inhibitor for Rho GTPase proteins including Rac and Cdc42 (Figure 7). Thus, it seems that activation of Rac or Cdc42 or both by Gi proteins is involved in the CCL19-induced morphologic change. Rho, Rac, and Cdc42 are responsible for reorganization of the actin cytoskeleton and subsequent morphologic changes in various cellular functions.18 Cross-talk between these proteins has been well documented in various cell culture systems. Cdc42 is a strong activator of Rac,21,22 whereas the actions of Rac and Rho counteract each other.51,52 Thus, cell morphology appears to result from complex reciprocal actions of these proteins. Recently, Yamaguchi et al53 have shown that nerve growth factor induces neurite outgrowth mediated via Rac activation, whereas Rho negatively regulates Rac activation through Rho-associated kinase-dependent pathway in PC12 rat pheochromocytoma cells. Similar results have been shown in neuroblastoma cells.38 In these studies, Y-27632 blocked negative regulation of neurite outgrowth mediated via Rho-associated kinase.38,52 On the other hand, it has been reported that rapid dendritic extension of chicken ganglion cells is inhibited by a dominant-negative form of Rac, but enhanced by a dominant-negative form of Rho.54 These findings suggest that the rapid dendritic extension is positively or negatively regulated by Rac or Rho, respectively. Although DCs possess a number of dendrites as ganglion cells do, no such reciprocal actions of Rac and Rho have been reported in the regulation of dendritic morphology of DCs. In the present study, we could show similar reciprocal actions of Rho GTPase proteins in the regulation of the dendritic extension of DCs. CCL19-induced dendritic extension of mature DCs was slightly but significantly enhanced by Y-27632 (Figure 7), a specific inhibitor for Rho-associated kinase.36 In addition, Y-27632 alone induced a significant dendritic extension. These observations suggest that the signal pathway mediated via Rho and Rho-associated kinase is involved in negative regulation of dendritic extension of mature DCs. On the contrary, the CCL19-induced dendritic extension of mature DCs was completely inhibited by toxin B, a specific inhibitor for Rho GTPase proteins (Figure 7). In this case, both CCL19-induced positive signals mediated via Rac and Cdc42 and negative signals mediated via Rho and Rho-associated kinase for dendritic extension seem to be completely inhibited by toxin B. We would like to postulate that the CCL19-induced dendritic extension is positively regulated by Rac or Cdc42 (or both), but negatively regulated by Rho. In the last experiment, we showed that not only BC1 cell line but also SPDCs that had been generated by culturing splenocytes in the presence of GM-CSF and fibroblast supernatant for 14 days exhibited CCL19-induced dendritic extension (Figure 8). We also tried to detect dendritic extension in freshly isolated DCs. However, a significant proportion of the freshly isolated DCs underwent apoptosis during the short-term culture (data not shown). We could not detect CCL19-induced dendritic extension in these DCs. It has been reported that more than 50% of freshly isolated DCs from lymphoid organs undergo apoptosis by only short-term culturing.55 Thus, it seems to us that physiologic dendritic extension is no more anticipated in the presence of massive cell death. We showed herein a novel role of CCL19 in the regulation of dendritic morphology of DCs. Because extended dendrites of DCs are thought to be of great advantage to interaction with T cells, CCL19 in the T-cell area of LNs appears to be an important component for the efficient antigen presentation. Thus, elucidation of the rather complex pathways controlling the CCL19-induced dendritic extension may lead to development of the new regulation system in various immune disorders in the clinical applications.
Submitted February 13, 2002; accepted April 23, 2002.
Prepublished online as Blood First Edition Paper, May 24, 2002; DOI 10.1182/blood-2002-01-0260.
Supported in part by a Grant-in-Aid for Scientific Research (B) by the Ministry of Education, Science, Japan. This study was also supported by grants from the Hokkaido Foundation for the Promotion of Scientific and Industrial Technology, and The Tomakomai East Hospital Foundation.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Kazunori Onoé, Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-0815 Japan; e-mail: kazunori{at}imm.hokudai.ac.jp.
1. Steinman R. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296[CrossRef][Medline] [Order article via Infotrieve].
2.
Hart DNJ.
Dendritic cells: unique leukocyte populations which control the primary immune response.
Blood.
1997;90:3245-3287 3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-251[CrossRef][Medline] [Order article via Infotrieve]. 4. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994;55:97-179[Medline] [Order article via Infotrieve]. 5. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Ann Rev Immunol. 1997;15:675-705[CrossRef][Medline] [Order article via Infotrieve].
6.
Rollins BJ.
Chemokines.
Blood.
1997;90:909-928 7. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol. 1994;6:865-873[CrossRef][Medline] [Order article via Infotrieve]. 8. Hedrick JA, Zlotnik A. Chemokines and lymphocyte biology. Curr Opin Immunol. 1996;8:343-347[CrossRef][Medline] [Order article via Infotrieve]. 9. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593-633[CrossRef][Medline] [Order article via Infotrieve]. 10. Murphy PM. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 1996;7:47-64[CrossRef][Medline] [Order article via Infotrieve].
11.
Bokoch GM.
Chemoattractant signaling and leukocyte activation.
Blood.
1995;86:1649-1660
12.
Dieu MC, Vanbervliet B, Vicari A, et al.
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
J Exp Med.
1998;188:373-386 13. Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leukoc Biol. 1999;66:252-262[Abstract].
14.
Sato K, Kawasaki H, Nagayama H, et al.
Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages.
Int Immunol.
2001;13:167-179
15.
Cyster JG.
Chemokines and cell migration in secondary lymphoid organs.
Science.
1999;286:2098-2102 16. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol. 2000;18:593-620[CrossRef][Medline] [Order article via Infotrieve]. 17. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99:23-33[Medline] [Order article via Infotrieve].
18.
Mackay DJ, Hall A.
Rho GTPases.
J Biol Chem.
1998;273:20685-20688 19. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70:389-399[CrossRef][Medline] [Order article via Infotrieve]. 20. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 1992;70:401-410[CrossRef][Medline] [Order article via Infotrieve]. 21. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 1995;81:53-62[CrossRef][Medline] [Order article via Infotrieve]. 22. Kozma R, Ahmed S, Best A, Lim L. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol Cell Biol. 1995;15:1942-1952[Abstract].
23.
Machesky LM, Hall A.
Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization.
J Cell Biol.
1997;138:913-926
24.
Winzler C, Rovere P, Rescigno M, et al.
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures.
J Exp Med.
1997;185:317-328 25. Villadangos JA, Cardoso M, Steptoe RJ, et al. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity. 2001;14:739-749[CrossRef][Medline] [Order article via Infotrieve].
26.
Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P.
Dendritic cell survival and maturation are regulated by different signaling pathways.
J Exp Med.
1998;188:2175-2180
27.
Rescigno M, Piguet V, Valzasina B, et al.
Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1
28.
Schuurhuis DH, Laban S, Toes RE, et al.
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.
J Exp Med.
2000;192:145-150 29. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001;2:361-367[CrossRef][Medline] [Order article via Infotrieve]. 30. Granucci F, Vizzardelli C, Pavelka N, et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol. 2001;2:882-888[CrossRef][Medline] [Order article via Infotrieve].
31.
Yanagawa Y, Iijima N, Iwabuchi K, Onoé K.
Activation of extracellular signal-related kinase by TNF-
32.
Campbell JJ, Pan J, Butcher EC.
Related developmental switches in chemokine responses during T cell maturation.
J Immunol.
1999;163:2353-2357
33.
Yanagawa Y, Iwabuchi K, Onoé K.
Enhancement of stromal cell-derived factor-1 34. Loetscher P, Moser B, Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv Immunol. 2000;74:127-180[Medline] [Order article via Infotrieve]. 35. Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol. 2000;12:336-341[CrossRef][Medline] [Order article via Infotrieve]. 36. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994[CrossRef][Medline] [Order article via Infotrieve]. 37. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature. 1995;375:500-503[CrossRef][Medline] [Order article via Infotrieve].
38.
Hirose M, Ishizaki T, Watanabe N, et al.
Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells.
J Cell Biol.
1998;141:1625-1636 39. Garrett WS, Chen LM, Kroschewski R, et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell. 2000;102:325-334[CrossRef][Medline] [Order article via Infotrieve]. 40. Massol P, Montcourrier P, Guillemot JC, Chavrier P. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J. 1998;17:6219-6229[CrossRef][Medline] [Order article via Infotrieve].
41.
Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG.
Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse.
Proc Natl Acad Sci U S A.
2000;97:12694-12699
42.
Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT.
A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.
Proc Natl Acad Sci. U S A.
1998;95:258-263 43. Willimann K, Legler DF, Loetscher M, et al. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol. 1998;28:2025-2034[CrossRef][Medline] [Order article via Infotrieve].
44.
Blanpain C, Migeotte I, Lee B, et al.
CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
Blood.
1999;94:1899-1905
45.
Loetscher P, Pellegrino A, Gong JH, et al.
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.
J Biol Chem.
2001;276:2986-2991 46. Post GR, Brown JH. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J. 1996;10:741-749[Abstract]. 47. Spangrude GJ, Sacchi F, Hill HR, van Epps DE, Daynes RA. Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J Immunol. 1985;135:4135-4143[Abstract].
48.
Cyster JG, Goodnow CC.
Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords.
J Exp Med.
1995;182:581-586
49.
Gutkind JS.
The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades.
J Biol Chem.
1998;273:1839-1842
50.
Ueda H, Morishita R, Yamauchi J, Itoh H, Kato K, Asano T.
Regulation of Rac and Cdc42 pathways by Gi during lysophosphatidic acid-induced cell spreading.
J Biol Chem.
2001;276:6846-6852 51. Kozma R, Sarner S, Ahmed S, Lim L. Rho family GTPases and neuronal growth cone remodeling: relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. Mol Cell Biol. 1997;17:1201-1211[Abstract].
52.
Chen XQ, Tan I, Leung T, Lim L.
The myotonic dystrophy kinase-related Cdc42-binding kinase is involved in the regulation of neurite outgrowth in PC12 cells.
J Biol Chem.
1999;274:19901-19905
53.
Yamaguchi Y, Katoh H, Yasui H, Mori K, Negishi M.
RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway.
J Biol Chem.
2001;276:18977-18983
54.
Wong WT, Faulkner-Jones BE, Sanes JR, Wong RO.
Rapid dendritic remodeling in the developing retina: dependence on neurotransmission and reciprocal regulation by Rac and Rho.
J Neurosci.
2000;20:5024-5036
55.
Park Y, Lee SW, Sung YC.
CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway.
J Immunol.
2002;168:5-8
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  C. Escribano, C. Delgado-Martin, and J. L. Rodriguez-Fernandez CCR7-Dependent Stimulation of Survival in Dendritic Cells Involves Inhibition of GSK3{beta} J. Immunol., November 15, 2009; 183(10): 6282 - 6295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Zidar, J. D. Violin, E. J. Whalen, and R. J. Lefkowitz Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands PNAS, June 16, 2009; 106(24): 9649 - 9654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Szameit, K. Vierlinger, L. Farmer, H. Tuschl, and C. Noehammer Microarray-Based In Vitro Test System for the Discrimination of Contact Allergens and Irritants: Identification of Potential Marker Genes Clin. Chem., March 1, 2008; 54(3): 525 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ziegler, M. Oberbarnscheidt, S. Bulfone-Paus, R. Forster, U. Kunzendorf, and S. Krautwald CCR7 Signaling Inhibits T Cell Proliferation J. Immunol., November 15, 2007; 179(10): 6485 - 6493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Unsoeld, K. Mueller, U. Schleicher, C. Bogdan, J. Zwirner, D. Voehringer, and H. Pircher Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections Int. Immunol., November 1, 2007; 19(11): 1281 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Tourkova, G. V. Shurin, S. Wei, and M. R. Shurin Small Rho GTPases Mediate Tumor-Induced Inhibition of Endocytic Activity of Dendritic Cells J. Immunol., June 15, 2007; 178(12): 7787 - 7793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cappello, T. Fraone, L. Barberis, C. Costa, E. Hirsch, A. R. Elia, C. Caorsi, T. Musso, F. Novelli, and M. Giovarelli CC-Chemokine Ligand 16 Induces a Novel Maturation Program in Human Immature Monocyte-Derived Dendritic Cells J. Immunol., November 1, 2006; 177(9): 6143 - 6151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Stachowiak, Y. Wang, Y.-C. Huang, and D. J. Irvine Homeostatic Lymphoid Chemokines Synergize with Adhesion Ligands to Trigger T and B Lymphocyte Chemokinesis J. Immunol., August 15, 2006; 177(4): 2340 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kitamei, K. Iwabuchi, K. Namba, K. Yoshida, Y. Yanagawa, N. Kitaichi, M. Kitamura, S. Ohno, and K. Onoe Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-{kappa}B (NF-{kappa}B), pyrrolidine dithiocarbamate J. Leukoc. Biol., June 1, 2006; 79(6): 1193 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sanchez-Sanchez, L. Riol-Blanco, and J. L. Rodriguez-Fernandez The Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells J. Immunol., May 1, 2006; 176(9): 5153 - 5159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Iijima, Y. Yanagawa, J. M. Clingan, and K. Onoe CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells Int. Immunol., September 1, 2005; 17(9): 1201 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Minami, Y. Yanagawa, K. Iwabuchi, N. Shinohara, T. Harabayashi, K. Nonomura, and K. Onoe Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions Blood, September 1, 2005; 106(5): 1685 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaiser, E. Donnadieu, J.-P. Abastado, A. Trautmann, and A. Nardin CC Chemokine Ligand 19 Secreted by Mature Dendritic Cells Increases Naive T Cell Scanning Behavior and Their Response to Rare Cognate Antigen J. Immunol., August 15, 2005; 175(4): 2349 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jansson, E. Barnes, P. Klenerman, M. Harlen, P. Sorensen, S. J. Davis, and P. Nilsson A Theoretical Framework for Quantitative Analysis of the Molecular Basis of Costimulation J. Immunol., August 1, 2005; 175(3): 1575 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. V. Shurin, I. L. Tourkova, G. S. Chatta, G. Schmidt, S. Wei, J. Y. Djeu, and M. R. Shurin Small Rho GTPases Regulate Antigen Presentation in Dendritic Cells J. Immunol., March 15, 2005; 174(6): 3394 - 3400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sanchez-Sanchez, L. Riol-Blanco, G. de la Rosa, A. Puig-Kroger, J. Garcia-Bordas, D. Martin, N. Longo, A. Cuadrado, C. Cabanas, A. L. Corbi, et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells Blood, August 1, 2004; 104(3): 619 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, Y.-J. Kim, C. Mantel, and H. E. Broxmeyer P-Selectin Enhances Generation of CD14+CD16+ Dendritic-Like Cells and Inhibits Macrophage Maturation from Human Peripheral Blood Monocytes J. Immunol., July 15, 2003; 171(2): 669 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yanagawa and K. Onoe CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities Blood, June 15, 2003; 101(12): 4923 - 4929. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
(TNF-
, and the production of interferon 
in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses.
J Exp Med.
2000;192:1661-1668